Addison Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $173K | Sell |
3,740
-265
| -7% | -$12.3K | 0.04% | 238 |
|
|
2025
Q1 | $244K | Buy |
4,005
+28
| +0.7% | +$1.71K | 0.07% | 176 |
|
|
2024
Q4 | $225K | Sell |
3,977
-633
| -14% | -$35.8K | 0.06% | 186 |
|
|
2024
Q3 | $239K | Buy |
4,610
+312
| +7% | +$16.1K | 0.07% | 190 |
|
|
2024
Q2 | $178K | Buy |
4,298
+281
| +7% | +$11.7K | 0.06% | 215 |
|
|
2024
Q1 | $218K | Buy |
4,017
+166
| +4% | +$9K | 0.07% | 176 |
|
|
2023
Q4 | $198K | Buy |
3,851
+731
| +23% | +$37.5K | 0.08% | 178 |
|
|
2023
Q3 | $181K | Buy |
3,120
+192
| +7% | +$11.1K | 0.08% | 169 |
|
|
2023
Q2 | $187K | Sell |
2,928
-19
| -0.6% | -$1.22K | 0.09% | 158 |
|
|
2023
Q1 | $204K | Buy |
2,947
+20
| +0.7% | +$1.39K | 0.11% | 138 |
|
|
2022
Q4 | $211K | Sell |
2,927
-732
| -20% | -$52.7K | 0.13% | 125 |
|
|
2022
Q3 | $260K | Buy |
3,659
+74
| +2% | +$5.26K | 0.16% | 101 |
|
|
2022
Q2 | $276K | Sell |
3,585
-147
| -4% | -$11.3K | 0.17% | 100 |
|
|
2022
Q1 | $273K | Buy |
3,732
+548
| +17% | +$40.1K | 0.15% | 109 |
|
|
2021
Q4 | $199K | Buy |
3,184
+647
| +26% | +$40.4K | 0.12% | 119 |
|
|
2021
Q3 | $150K | Buy |
2,537
+12
| +0.5% | +$709 | 0.12% | 100 |
|
|
2021
Q2 | $169K | Buy |
+2,525
| New | +$169K | 0.14% | 92 |
|
|
2020
Q4 | $164K | Buy |
+2,650
| New | +$164K | 0.16% | 90 |
|